| Literature DB >> 30565136 |
Ryan J Quinton1, Neil J Ganem2,3.
Abstract
The advent of CRISPR has revolutionized genomic engineering, and harnessing its power to regulate levels of the transcriptional co-activators YAP and TAZ represents an exciting new opportunity in the field of Hippo signaling. Initially repurposed from the microbial immune system to perform highly specific gene knockouts, CRISPR technology has now been expanded to modulate the transcriptional activity of any gene of interest in mammalian systems. Here, we describe strategies to employ CRISPR to genetically knock out the genes encoding for YAP (YAP1) or TAZ (WWTR1) in mammalian cell lines, as well as briefly outline an approach for utilizing CRISPR to transcriptionally modulate YAP/TAZ levels.Entities:
Keywords: CRISPRa; CRISPRi; Cas9; Hippo; KRAB; LATS; VP64; sgRNA
Mesh:
Substances:
Year: 2019 PMID: 30565136 PMCID: PMC6533617 DOI: 10.1007/978-1-4939-8910-2_16
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745